BMT ACCESS: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date3/16/223/15/25

Funding

  • National Marrow Donor Program (Adekola AGMT 4/4/22)